OLMSTED MEDICAL CENTER
1. Target Overview & Investment Thesis
OLMSTED MEDICAL CENTER is a 61-bed under-performing / distressed in OLMSTED, MN with $217.6M in net patient revenue and a -13.6% operating margin. The hospital serves a payer mix of 15.5% Medicare, 7.6% Medicaid, and 76.9% commercial.
Thesis: Turnaround. Our ML models identify $16.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -13.6% to -6.3% (+736bps).
| Net Revenue HCRIS | $217.6M |
| Current EBITDA COMPUTED | $-29.7M |
| Operating Margin COMPUTED | -13.6% |
| Occupancy HCRIS | 31.7% |
| Revenue / Bed COMPUTED | $3.6M |
| Net-to-Gross HCRIS | 45.7% |
| Distress Probability ML | 50.8% |
2. Market Context & Competitive Position
MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -13.6% places it below the state median. Among 28 size-comparable peers (30-122 beds), the median margin is -5.5%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (30-122), prioritizing same-state peers. 28 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| OLMSTED MEDICAL CENTER (Target) | MN | 61 | $217.6M | -13.6% |
| SMDC MEDICAL CENTER | MN | 118 | $519.2M | -7.1% |
| MCHS - SOUTHWEST MINNESOTA REG | MN | 118 | $473.6M | -9.8% |
| LAKEVIEW MEMORIAL | MN | 68 | $411.9M | 60.9% |
| SANFORD BEMIDJI | MN | 94 | $312.6M | -19.6% |
| RIDGEVIEW MEDICAL CENTER | MN | 109 | $287.8M | -14.2% |
| MAYO CLNIC HLTH SYS-ALBRT LEA | MN | 79 | $271.9M | -16.6% |
| GILLETTE CHILDRENS SPECIALTY H | MN | 60 | $266.7M | -6.3% |
| HEALTHEAST WOODWINDS HOSPITAL | MN | 86 | $210.3M | -5.5% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $16.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $4.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $4.4M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $4.3M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $2.6M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $139K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-29.7M |
| + RCM Uplift | +$16.0M |
| Pro Forma EBITDA | $-13.7M |
| Current Margin | -13.6% |
| Pro Forma Margin | -6.3% |
| WC Released (1x) | $8.3M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-45.7M | $-35.7M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-45.7M | $-54.2M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-41.1M | $-16.1M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-41.1M | $-29.7M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-50.3M | $-101.0M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-50.3M | $-127.4M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 31.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 50.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 28 hospitals with 30-122 beds
- Same-state prioritization (n=29)
- Comp margins: P25=-10.0% / P50=-5.5% / P75=0.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.